Adherence Measurement in stable renal transplant patients following conversion form Prograft to advagraf - Admirad

KULeuven0 个研究点开始时间: 2008年8月1日最近更新: 2012年3月19日

适应症

试验速览

暂无简介。

•Adult patients
•transplanted min 6m and max 6years at inclusion time
•prograft based stable immunosuppressive regimen for at least 3 months
•patients able to understand purpose and manipulation of Pro Mate electronic monitoring device
•first or second renal transplantation
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•patient with known clinical need at inclusion of withdrawing prograft from regimen within a period of 9 months after inclusion
•patients not able to understand manipulation of ProMate electronic monitoring device
•patients refusing signature of informed consent
•interruption of prograft /advagraf regimen for more then 10 consecutive days
•medical reasons rendering the patient not suitable for inclusion

发起方

KULeuven